Immune cells, especially CD68+ macrophages, were more abundant in the NP+ group than in the NP− group, suggesting a potential crucial role for these cells in COVID-19-related inflammation and GI symptoms (Figure 2C) (Lehmann et al., 2021). Here, CD68 is linked to COVID-19.